Redshift Bio

The Future of Biomolecule Structural Analysis

Redshift Bio was founded in 2005, is headquartered in BOXBOROUGH, United States, lists 51–200 employees, and has $26.4M in recorded funding across 2 rounds.

Employees
51–200
Founded
2005
Business Model
B2B
Total Funding
$26.4M
Last Round
$20.0M Series EOct 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

RedShiftBio (RedShift BioAnalytics, Inc.) is a life sciences instrumentation company that has developed a proprietary platform combining Microfluidic Modulation Spectroscopy (MMS) and high-powered quantum cascade lasers to provide ultra-sensitive, ultra-precise measurements of biomolecular structure and concentration. Their Aurora and Aurora TX instruments and HaLCon bioprocess analytics platform are used by leading biopharmaceutical companies and CDMOs worldwide to characterize proteins, RNA, and other biomolecules during drug development and manufacturing. RedShiftBio is backed by Waters Corporation, Illumina Ventures, and Technology Venture Partners, and is headquartered in Boxborough, Massachusetts.

Summary

Redshift Bio is a Biotech company based in BOXBOROUGH, United States, founded in 2005. It lists 51–200 employees. It has raised $26.4M in total across 2 rounds, most recently a $20.0M Series E round in Oct 2021. Investors include Illumina Ventures, Technology Venture Partners and Waters Corporation.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries EOct 2021
$20.0M

Sign up to see all 2 events

Funding: Extension Round through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Redshift Bio on Indexed.vc
<a href="https://indexed.vc/companies/redshift-bio"><img src="https://indexed.vc/api/badge/company/redshift-bio" alt="Redshift Bio on Indexed.vc" width="260" height="76" /></a>